"Outcomes of Tracheostomy Done for Patients Admitted in Anesthesia

Status Completed

Clinical Trial Summary

This study was undertaken to Identify the factors affecting the outcomes of tracheostomy done in ICU for patients subjected to prolonged intubation and ventilation and to suggest guidelines to control:

1. proper timing of tracheostomy

2. process of decannulation.

Clinical Trial Description

Tracheostomy is described as the creation of a stoma at the skin surface which leads into the trachea. From the first tracheostomy until about 1930, the operation was performed exclusively for laryngeal obstruction. Nowadays, due to the development of the care of critically ill patients in intensive care units (ICUs), there are other indications for the procedure including prolonged intubation and pulmonary toilet.

The initial management of patients in an intensive care unit involves a series of interventions that aim to stabilize and then optimize their physiological state. Mechanical ventilation (MV) is a commonly utilized intervention to support a patient's respiratory function. The second phase in ICU management focuses on weaning the patient from the artificial supportive mechanisms.

The principle role of tracheostomy in the ICU is to expedite the weaning process in patients requiring prolonged mechanical ventilation and those predicted to be at risk of pulmonary aspiration. Tracheostomy facilitates weaning primarily by allowing increased level of patient activity and mobility.

Tracheostomy protects the larynx and the upper airway from prolonged intubation which may lead to laryngotracheal stenosis. Patients with tracheostomies tend to have fewer days of mechanical ventilation because of the improvements in the respiratory physiology. This is especially in trauma patients. They have improved secretion clearance as suction is easy and less strength is required for expectoration. This may be linked to the lower incidence of pneumonia and respiratory infections seen, especially in trauma victims.

Patients with tracheostomy are less sedated and therefore able to move in bed. The patients may also be able to swallow, so may be started on oral feeding sooner and mouth care is easier compared with an endotracheal tube (ETT) tube. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03431389
Study type	Interventional
Source	Assiut University
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	June 1, 2015
Completion date	May 31, 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05084976` - Parental Perception of COVID-19 Vaccine in Technology Dependent Patients
Active, not recruiting	`NCT04308109` - Simulation Training in the Pediatric Tracheostomy and Home Ventilator Population	N/A
Recruiting	`NCT02495558` - Cough Assessment in Patients With Severe Acquired Brain Injury	N/A
Completed	`NCT04637932` - Percutaneous Dilatation Tracheostomy, Broncoscopy, Pro-seal Laryngeal Mask	N/A
Completed	`NCT05499273` - Pediatric Neck Rescue Access Comparison	N/A
Recruiting	`NCT04565405` - Microbiological Evaluation of the Efficacy of Water to Clean Tracheostomy Inner Cannulas	N/A
Recruiting	`NCT05395728` - Deflating the Tracheostomy Tube Cuff and Time for Decannulation	N/A
Withdrawn	`NCT02074254` - Safety of Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin Reuptake Inhibitors
Not yet recruiting	`NCT02096640` - Postoperative Inflammation and Recovery After Tracheostomy	N/A
Completed	`NCT05045885` - Safety and Feasibility of Percutaneous Dilatational Tracheostomy in Patients With Severe COVID-19 Supported by ECMO
Completed	`NCT04744909` - Navigation System for Percutaneous Tracheotomy	N/A
Completed	`NCT04412356` - Timing of Tracheotomy in Covid-19 Patients	N/A
Recruiting	`NCT06018220` - Percutaneous Dilatational Tracheostomy vs. Surgical Tracheostomy in Neurocritically Ill Patients - a Retrospective Study
Not yet recruiting	`NCT05834972` - Ultrasound-guided Versus Landmark-guided Percutaneous Dilational Tracheostomy in Pediatric Patients
Not yet recruiting	`NCT05418517` - Hospital Acquired Pneumonia in Temporary Tracheostomy
Withdrawn	`NCT04685902` - Assessing Upper Airway Patency in Tracheostomy Patients During One Way Speaking Valve Trial
Completed	`NCT04987398` - Ventilation Weaning Strategies and Correlation to Outcomes in Tracheostomized Patients in the Lausanne ICU
Withdrawn	`NCT03325725` - Intra-laryngeal Implant for Treatment of Chronic Aspirations	N/A
Completed	`NCT05595707` - Expert-Guided Early Tracheostomy Pathway	N/A
Recruiting	`NCT06226142` - The Ultrasound-guided vs Bronchoscopy-guided vs Ultrasound-bronchoscopy-guided Percutaneous Tracheostomy Trial	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

"Outcomes of Tracheostomy Done for Patients Admitted in Anesthesia Intensive Care Units of Assiut University Hospital" — PITS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms